Melvin Lafeber
Erasmus MC(NL)
Publications by Year
Research Areas
Medication Adherence and Compliance, SARS-CoV-2 and COVID-19 Research, Pharmaceutical Economics and Policy, Blood Pressure and Hypertension Studies, COVID-19 Clinical Research Studies
Most-Cited Works
- → Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming(2022)127 cited
- → Association between Clinical Frailty Scale score and hospital mortality in adult patients with COVID-19 (COMET): an international, multicentre, retrospective, observational cohort study(2021)111 cited
- → Comparison of a morning polypill, evening polypill and individual pills on LDL-cholesterol, ambulatory blood pressure and adherence in high-risk patients; a randomized crossover trial(2014)62 cited
- → The combined use of aspirin, a statin, and blood pressure–lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease(2013)56 cited
- → Absence of major fibrotic adverse events in hyperprolactinemic patients treated with cabergoline(2010)52 cited
- → Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial(2023)35 cited
- → Impact of switching from different treatment regimens to a fixed-dose combination pill (polypill) in patients with cardiovascular disease or similarly high risk(2017)32 cited
- → Screening of cardiovascular agents in plasma with LC-MS/MS: A valuable tool for objective drug adherence assessment(2019)31 cited
- → The cardiovascular polypill in high-risk patients(2011)27 cited
- → Multifactorial Prevention of Cardiovascular Disease in Patients with Hypertension: the Cardiovascular Polypill(2016)21 cited